期刊文献+

Current practice of gastric cancer treatment

Current practice of gastric cancer treatment
原文传递
导出
摘要 Objective The aim of this review was to overview the current practice of gastric cancer treatment including surgery and other adjuvant modalities.Data sources The review was based on data obtained from the published articles and main guidelines in the East and West.Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed.Results Although varied adjuvant modalities have been proved to be benefit for treating gastric cancer,surgery is still the most important treatment strategy against gastric cancer.Actively adapting to new technology is important but it should be balanced with an effort to establish sound scientific rationale that adheres to oncologic principles.Conclusions Future treatment of gastric cancer will be focused on tailored,personalized therapy.For achieving it,collaboration across disciplines is essential.Also the philosophy of caring for the patients with gastric cancer should be rooted in the realization of true patient benefit regardless of who is providing the care.With these philosophies,we can shift the scientific and technological advances toward triumph over gastric cancer. Objective The aim of this review was to overview the current practice of gastric cancer treatment including surgery and other adjuvant modalities.Data sources The review was based on data obtained from the published articles and main guidelines in the East and West.Study selection Articles with high level of evidence or current best evidence in each issue were selected to be reviewed.Results Although varied adjuvant modalities have been proved to be benefit for treating gastric cancer,surgery is still the most important treatment strategy against gastric cancer.Actively adapting to new technology is important but it should be balanced with an effort to establish sound scientific rationale that adheres to oncologic principles.Conclusions Future treatment of gastric cancer will be focused on tailored,personalized therapy.For achieving it,collaboration across disciplines is essential.Also the philosophy of caring for the patients with gastric cancer should be rooted in the realization of true patient benefit regardless of who is providing the care.With these philosophies,we can shift the scientific and technological advances toward triumph over gastric cancer.
机构地区 Department of Surgery
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第3期547-553,共7页 中华医学杂志(英文版)
关键词 gastric cancer TREATMENT ONCOLOGY gastric cancer treatment oncology
  • 相关文献

参考文献72

  • 1Jemal A,Siegel R,Xu J,Ward E.Cancer statistics,2010.CA Cancer J Clin 2010; 60:277-300.
  • 2Nakajima T.Gastric cancer treatment guidelines in Japan.Gastric Cancer 2002; 5:1-5.
  • 3Robert CB,Donald WK,Raphael EP,Ralph RW,James FH,Emil FI.Holland-Frei Cancer Medicine.5th ed.Hamilton (ON):BC Decker; 2000.
  • 4Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2010 (ver.3).Gastric Cancer 2011; 14:113-123.
  • 5Sano T,Sasako M,Yamamoto S,Nashimoto A,Kurita A,Hiratsuka M,et al.Gastric cancer surgery:morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.J Clin Oncol 2004;22:2767-2773.
  • 6Sasako M,Sano T,Yamamoto S,Kurokawa Y,Nashimoto A,Kurita A,et al.D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.N Engl J Med 2008; 359:453-462.
  • 7Bonenkamp JJ,Hermans J,Sasako M,van de Velde C J,Welvaart K,Songun I,et al.Extended lymph-node dissection for gastric cancer.N Engl J Med 1999; 340:908-914.
  • 8Cuschieri A,Weeden S,Fielding J,Bancewicz J,Craven J,Joypaul V,et al.Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial.Surgical Co-operative Group.Br J Cancer 1999; 79:1522-1530.
  • 9Cunningham D,Allum WH,Stenning SP,Thompson JN,Van de Velde C J,Nicolson M,et al.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.N Engl J Med 2006; 355:11-20.
  • 10Macdonald JS,Smalley SR,Benedetti J,Hundahl SA,Estes NC,Stemmermann GN,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.N Engl J Med 2001; 345:725-730.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部